mDPR-Val-Cit-PAB-MMAE TFA is a drug-linker conjugate for ADC, combining MMAE, a tubulin polymerization inhibitor, with a protease-sensitive Val-Cit peptide. It targets cancer cells by attaching to monoclonal antibodies, delivering the MMAE anticancer payload. The maleimide moiety can react with cysteine or other thiol molecule for bioconjugation.
Products > PEG Linkers > GGFG Linkers | Products > ADC Linker, ADC Payload > Cleavable Linkers > Val-Cit-MMAE | Products > ADC Linker, ADC Payload > ADC Payload > MMAE
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。